Drug Approval | September 28, 2024
FDA approves Bristol Myers Squibb’s Cobenfy
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Quinidine Sulphate helps manage rare irregular heartbeat conditions
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
KEYTRUDA is the first and only immunotherapy-based regimen to show a statistically significant and clinically meaningful improvement in overall survival
Subscribe To Our Newsletter & Stay Updated
